期刊文献+

慢性HCV感染者外周血自然杀伤细胞亚群的检测及临床意义 被引量:2

Determination of peripheral blood natural killer cell subsets in patients with chronic HCV infection and analysis of its clinical significance
下载PDF
导出
摘要 目的检测慢性HCV感染者外周血自然杀伤细胞(natural killer cells,NK细胞)不同亚群的比例,并分析临床意义。方法采用流式细胞仪技术,检测慢性HCV感染者外周血NK细胞亚群的比例,并观察抗病毒治疗前后NK细胞亚群的变化及与抗病毒疗效的关系。结果与对照组比较,慢性HCV感染组外周血NK细胞中NKdim亚群比例低,NKnegative亚群高(P均<0.05);抗病毒治疗后NKbright亚群比例上升,NKdim亚群下降(P均<0.05);抗病毒治疗有效组NKbright亚群比例低于无效组,NKdim亚群比例高于无效组(P均<0.05)。结论慢性HCV感染者NK细胞亚群较健康人群有差异,且与抗病毒疗效相关。 Objective To determine the frequencies of different subsets of peripheral blood natural killer (NK) cells in patients with chronic HCV infection, and to investigate the NK subset changes and its clinical significance. Methods Flow cytometry was used to determine the frequencies of different subsets of peripheral blood NK ceils in patients with chronic HCV infection, and the corre- lation between the changes in NK cell subsets before and after antiviral therapy and antiviral efficacy was analyzed. Results Compared to the healthy controls, the frequency of NK subset was lower (P〈0.05), and that of NK subset higher in chronic HCV patients (P〈0.05). After antiviral treatment, the frequency of NKb subset increased (P〈0.05), and that of NK subset decreased (P〈0.05). The patients with early virological response exhibited a lower frequency of NKsht subset and a higher frequency of NKm subset than those with no antiviral response (P〈0.05). Conclusions Peripheral blood NK cell subsets in patients with chronic HCV infection differ from those of healthy controls and are correlated with antiviral efficacy.
出处 《传染病信息》 2013年第2期100-102,共3页 Infectious Disease Information
基金 国家自然科学基金面上项目(81170391/H0316)
关键词 丙型肝炎病毒 杀伤细胞 天然 干扰素类 hepacivirus killer ceils, natural interferons
  • 相关文献

参考文献4

二级参考文献21

  • 1戴志澄,祁国明.中国病毒性肝炎血清流行病学调查(上卷),1992-1995.北京:科学技术文献出版社,1995:60-71.
  • 2Liang XF, Bi SL, Yang WZ, et al. Epidemiological serosurvey of hepatitis B in China--declining HBV prevalence due to hepatitis B vaccination. Vaccine, 2009,27 : 6550-6557.
  • 3卫生部.全国人群乙型病毒性肝炎血清流行病学调查报告.北京:人民卫生出版社,2011:1-70.
  • 4Alberti A, Benvegnu L. Management of hepatitis C. J Hepatol, 2003,38 Suppl: S 1042-1048.
  • 5Halasz R, Weiland O, Sallberg M. GB virus C/hepatitis G virus. Scand J Infect Dis, 2001,33 (8) : 572-580.
  • 6Shepard CW, Finelli L, Alter MJ. Global epidemiology of hepatitis C infection. Lancet Infect Dis, 2005,5 : 558-567.
  • 7Esteban JI, Sauleda S, Quer J. The changing epidemiology of hepatitis C virus infection in Europe. J Hepatol, 2008, 48: 148-162.
  • 8Mele A, Tosti ME, Marzolini A, et al. Prevemion of hepatitis C in Italy: lessons from surveillance of type-specific acute viral hepatitis. SEIEVA Collaborating Group. J Viral Hepat, 2000, 7 : 30-35.
  • 9Stroffolini T. The changing pattern of hepatitis B virus infection over the past three decades in Italy. Dig Liver Dis, 2005, 37: 622-628.
  • 10Fabris P, Baldo V, Baldovin T, et al. Changing epidemiology of HCV and HBV infections in Northern Italy. A survey in the general population. J Clin Gastroenterol, 2008,42: 527-532.

共引文献340

同被引文献19

  • 1张平,章崇杰,刘杰,魏大鹏,赵宗容.改良MTT法检测自然杀伤细胞的活性[J].华西医科大学学报,1996,27(2):213-215. 被引量:32
  • 2包图雅,于娜沙,曾抗,李莉,方亮.梅毒血清固定患者细胞免疫功能研究[J].实用预防医学,2006,13(2):254-255. 被引量:29
  • 3Sun JC, Lanier LL. Natural killer cells remember: an evolutionarybridge between innate and adaptive immunity [J] . Eur JImmunol, 2009, 39(8):2059-2064.
  • 4Domaica Cl, Fuertes MB, Rossi LE, et al. Tumour-experienced Tcells promote NK cell activity through trogocytosis of NKG2D andNKp46 ligands [J] . EMBO Rep, 2009, 10(8):908-915.
  • 5Kohga K, Takehara T,Tatsumi T, et al. Serum levels of solublemajor histocompatibility complex (MHC) class I-related chainA in patients with chronic liver diseases and changes duringtranscatheter arterial embolization for hepatocellular carcinoma[j].Cancer Sci, 2008, 99(8):1643-1649.
  • 6Kamimura H, Yamagiwa S,Tsuchiya A, et al. Reduced NKG2Dligand expression in hepatocellular carcinoma correlates with earlyrecurrence [J] . J Hepatol, 2012,56(2):381-388.
  • 7Sha WH, Zeng XH, Min L. The correlation between NK cell andliver function in patients with primary hepatocellular carcinoma[j].Gut Liver, 2014, 8(3):298-305.
  • 8Demaria S, Pilones KA, Vanpouille-Box C, et al. The optimalpartnership of radiation and immunotherapy: from preclinicalstudies to clinical translation [J] . Radiat Res, 2014, 182(2):170-181.
  • 9Wu Y, Kuang DM, Pan WD,et al. Monocyte/macrophage-elicitednatural killer cell dysfunction in hepatocellular carcinoma ismediated by CD48/2B4 interactions [j] , Hepatology, 2013,57(3):1107-1116.
  • 10Zhang C, Niu J, Zhang J, et al. Opposing effects of interferon-alphaand interferon-gamma on the expression of major histocompatibilitycomplex class I chain-related A in tumors [J] . Cancer Sci, 2008,99(6):1279-1286.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部